Startups
gMendel
Copenhagen, Denmark
gMendel is a Copenhagen genetic-diagnostics and medical-software company, legally gMendel ApS, Danish CVR41505524. Founded in2020 by Chris (registered Christos) Kyriakidis, Zoran Velkoski and Hanna Pyokari, it develops Phivea and Test-SCAN software combining genomic sequencing, AI and machine learning to support screening and diagnosis of genetic and rare disorders, including neurological conditions. Its current directory identifies nine executives and advisers; earlier2022–2023 professional and board affiliations are separately dated. The company reports Danish registration and CE marking of Phivea v1 under the former EU IVDD; this audit independently verified its legal company in the Danish Medicines Agency register, not an individual product certificate or FDA approval. Its genuine LRQA ISO13485:2016 certificate, issued June11,2026 and expiring June10,2029, covers design, development and service of in-vitro-diagnostic medical-device software: a quality-system certification, not a treatment approval or independent proof of diagnostic performance. Business roadmaps and expansion pilots are distinguished from clinical-trial phases and commercial revenue. A completed DKK9M seed round announced April16,2026 was led by Metavallon VC. Earlier disclosures identify approximate2022 angel funding,2023 CVX-network backing and limited2025 financing from iFutura and Quaternity; amounts, exact payment dates and underlying instruments are not invented. Innovation Fund Denmark awarded separate Innobooster2022–2023 and Eurostars2023–2025 contributions, with project budgets distinct from support and paid cash unpublished. The issuer’s May2022 EUR200K grant report is preserved alongside the grantor’s DKK1,320,988 programme figure without assumed currency equivalence or an additional duplicate award. Cumulative EUR1.8M pre-seed reporting, funding targets, loan balances and applications are not represented as additional completed cash rounds.
Founded 2020
Team
 Agnieszka TymoszykQuality Assurance (published January2023) |
 Aleksandar NikovHead of AI (published January2023) |
 Anne Kristine SchackGenomics Researcher (published2023–2024) |
 Antonina BurlachenkoHead of Regulatory and Quality Assurance (CRQA) |
 Carmen Garrido NavasChief Scientific Officer · Clinical Evaluation (published January2023) |
 Chris KyriakidisChief Executive Officer · Co-founder · Executive Director (signed2022 annual report) |
Dariusz NablotczykSoftware Architect (published January2023) |
 David GalevskiData Scientist (published January2023) |
 Deepak AsudaniBoard Member (published2023) |
 Dimitrios KyriakidisChief Commercial Officer · Advocacy and Sales Development (published January2023) |
 Gjorgji MadjarovChief Artificial Intelligence Officer · AI Advisor (published January2023) |
 Hanna PyokariCo-founder and Board Member (published2022–2023) · Co-founder |
 Johan LeonhardLegal Advisor |
Karmele Alapont CelayaGenomics Researcher (published2023–2024) |
 Ken Ndugga-KabuyeUS Market Advisor (published January2023) |
 Kristijan JankoskiSenior Data Scientist (published January2023) |
 Lars Staal WegnerChair of the Board (historical2022–2023) |
 Lukasz KrychGenomic Advisor |
Marija AndrileouMarketing and Communications (published January2023) |
 Marija ChaushevskaAI Researcher (published January2023) |
Tomas PukHead of Quality by Design (published January2023) |
Wouter HamelAdvocacy and Sales Development (published January2023) |
 Zoran VelkoskiChief Technology Officer · Co-founder · Board Member (signed2022 annual report) |
 Zoran ZdraveskiChair of the Board · Strategic Advisor (published January2023) |